Remifentanil: achieving a 'standard concentration': a reply
- PMID: 35514203
- DOI: 10.1111/anae.15749
Remifentanil: achieving a 'standard concentration': a reply
Comment on
-
Remifentanil: achieving a 'standard concentration'.Anaesthesia. 2022 Aug;77(8):943. doi: 10.1111/anae.15740. Epub 2022 Apr 16. Anaesthesia. 2022. PMID: 35429342 No abstract available.
References
-
- Winter V, Moore C. Remifentanil: achieving a ‘standard concentration’. Anaesthesia 2022. Epub 16 April. https://doi.org/10.1111/anae.15740
-
- Misra U, Abbott H, Bailey K, et al. Controlled Drugs in Peri-operative Care - 2019. London: Association of Anaesthetists. 2019. https://doi.org/10.21466/g.CDIPC.2006 (accessed 25/04/2022).
-
- Wockhardt UK Ltd. Remifentanil 5 mg powder for concentrate for solution for injection or infusion - summary of product characteristics. Electronic Medicines Compendium. 2022. https://www.medicines.org.uk/emc/product/3333/smpc#gref (accessed 25/04/2022).
-
- Wheeler DW, Degnan BA, Sehmi JS, et al. Variability in the concentrations of intravenous drug infusions prepared in a critical care unit. Intensive Care Medicine 2008; 34: 1441-7.
-
- Adapa RM, Mani V, Murray LJ, et al. Errors during the preparation of drug infusions: a randomized controlled trial. British Journal of Anaesthesia 2012; 109: 729-34.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources